Bio-Rad to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, February 13, 2025

Rhea-AI Summary

Bio-Rad Laboratories (NYSE: BIO and BIO.B) has announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 13, 2025, after market close. The company will host a conference call at 2 PM Pacific Time (5 PM Eastern Time) to discuss the results. Investors can join via phone by dialing (800) 715-9871 (U.S.) or (646) 307-1963 (international) using access code 9562470. A live webcast will be available in the Investor Relations section of Bio-Rad's website, with the replay accessible for up to one year.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year of 2024 on Thursday, February 13, 2025, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

To participate, dial (800) 715-9871 within the U.S. or (646) 307-1963 outside the U.S., access code: 9562470. A live webcast of the conference call will also be available in the "Investor Relations" section of the company’s website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 7,700 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, and biopharmaceutical companies, as well as clinical, food safety and environmental quality laboratories. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250127206889/en/

Investor Contact:

Edward Chung, Investor Relations

510-741-6104

ir@bio-rad.com

Media Contact:

Anna Gralinska, Corporate Communications

510-741-6643

cc@bio-rad.com

Source: Bio-Rad Laboratories, Inc.

FAQ

When will Bio-Rad (BIO) report its Q4 and full year 2024 earnings?

Bio-Rad will report its Q4 and full year 2024 financial results on Thursday, February 13, 2025, after market close.

How can investors access Bio-Rad's Q4 2024 earnings call?

Investors can access the call by dialing (800) 715-9871 (U.S.) or (646) 307-1963 (international) with access code 9562470, or via webcast in the Investor Relations section of Bio-Rad's website.

What time is Bio-Rad's Q4 2024 earnings conference call?

Bio-Rad's earnings conference call is scheduled for 2 PM Pacific Time (5 PM Eastern Time) on February 13, 2025.

How long will Bio-Rad's Q4 2024 earnings webcast be available for replay?

The webcast replay will be available for up to one year in the Investor Relations section of Bio-Rad's website.